by reason for retraction – Page 397

University investigating leading German derm lab that retracted Immunology paper

The laboratory of Michael Hertl, a German dermatology researcher with an international reputation, is under investigation for possible misconduct, according to a legal official at Hertl’s institution, Philipps-Universitat Marburg.

The acknowledgement was prompted by our query earlier this week about a 2008 paper from Hertl’s group that had been retracted by the journal Immunology. According to the July 25 retraction notice: Continue reading University investigating leading German derm lab that retracted Immunology paper

Physics paper retracted “on ethical grounds” — aka the data had already been published

There was a curious retraction published online last month in Physica Scripta, an Institute of Physics journal. The notice, for “Response of Cu 0.5 (Tl 0.5-y Hg y)Ba 2 Ca 3 Zn 2 Cu 2 O 12-δ (y =0, 0.15, 0.25 and 0.35) superconductors in electric and magnetic fields,” reads as follows: Continue reading Physics paper retracted “on ethical grounds” — aka the data had already been published

Angiogenesis retracts two papers, cites image manipulation in eight, as PI blames unethical students

The journal Angiogenesis is retracting two articles by a group of researchers in India whom it accuses of using manipulated images in six other publications as well.

According to the retraction notice for one of the papers, “Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src
dependent pathway in retinal endothelial cells” (we’ve annotated with links and citation data): Continue reading Angiogenesis retracts two papers, cites image manipulation in eight, as PI blames unethical students

Should we change our name to Mori Watch? Yet another retraction from cancer researcher

Earlier this week we reported on the latest retraction of an article by Naoki Mori, number 21 in a series. We could have waited a few days and saved ourselves some trouble.

The journal Leukemia Research has retracted a 2006 paper by Mori, titled “Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.” From the notice, which is behind a paywall: Continue reading Should we change our name to Mori Watch? Yet another retraction from cancer researcher

Another for Mori: 1999 Infection and Immunity paper pulled

When we first wrote about Naoki Mori last December, one question we had was why Infection and Immunity, the journal that got the ball rolling in this case, wasn’t retracting a 1999 article by the serial manipulator. Well, it has.

The August issue of the journal, a publication of the American Society of Microbiology — which levied a 10-year ban on Mori for his misdeeds — contains the following retraction notice: Continue reading Another for Mori: 1999 Infection and Immunity paper pulled

Carsten Carlberg out at University of Luxembourg

The University of Luxembourg has fired researcher Carsten Carlberg after concluding that his name was a drag on the institution.

Here’s an English translation of an article about the firing, which many readers were kind enough to forward to us: Continue reading Carsten Carlberg out at University of Luxembourg

Cryptic “legal issues” lead to retraction of paper about potential Novartis alcohol abuse drug

Readers of this blog by now know that if there’s one thing that really gets us going, it’s obfuscation. So it shouldn’t be surprising that the following retraction notice from the journal Psychopharmacology, made us particularly batty:

This paper has been retracted by the author because of legal issues.

The notice refers to “Selective activation of the metabotropic glutamate receptor subtype 7 “mGluR7” attenuates acquisition, expression, and reinstatement of ethanol place preference,” was published online in late June by Amine Bahi under the heading “Original Investigation.”

Bahi is in the department of anatomy at United Arab Emirates University. He has also held positions at Yale and the University of Fribourg in Switzerland. Among his publications is one that involved a collaborator from Novartis (more on that in a moment). Continue reading Cryptic “legal issues” lead to retraction of paper about potential Novartis alcohol abuse drug

University of Louisville investigating work by team under review at Emory

On Tuesday, we reported that Emory University in Atlanta was looking into why a team of former researchers — now at the University of Louisville — had retracted three papers in the Journal of Biological Chemistry (JBC).

Today, we learned that the researchers’ home institution since 2009 is now investigating the work. A spokesperson tells Retraction Watch: Continue reading University of Louisville investigating work by team under review at Emory